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Abstract The low molecular weight phosphotyrosine protein
phosphatase (LMW-PTP) is phosphorylated by Src and Src-
related kinases both in vitro and in vivo; in Jurkat cells, and in
NIH-3T3 cells, it becomes tyrosine-phosphorylated upon stimu-
lation by PDGF. In this study we show that pp60Src phosphor-
ylates in vitro the enzyme at two tyrosine residues, Tyr131 and
Tyr132, previously indicated as the main phosphorylation sites of
the enzyme, whereas phosphorylation by the PDGF-R kinase is
much less effective and not specific. The effects of LMW-PTP
phosphorylation at each tyrosine residue were investigated by
using Tyr131 and Tyr132 mutants. We found that the phosphor-
ylation at either residue has differing effects on the enzyme
behaviour: Tyr131 phosphorylation is followed by a strong (about
25-fold) increase of the enzyme specific activity, whereas
phosphorylation at Tyr132 leads to Grb2 recruitment. These
differing effects are discussed on the light of the enzyme
structure.
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1. Introduction
Protein tyrosine phosphorylation is a crucial event in the
regulation of cell proliferation, di¡erentiation and chemotaxis
[1^3]. Protein tyrosine phosphatases (PTPs) contribute to the
protein phosphorylation balance by counteracting the role of
protein tyrosine kinases. On the basis of structural and kinetic
features, PTPs are currently grouped into four classes: tyro-
sine speci¢c PTPs (receptor-like and soluble), VH1-like dual
speci¢city PTPs, cdc25, and low molecular weight PTPs
(LMW-PTP) displaying very limited sequence similarity,
though sharing a common active site motif (CX5R) and cata-
lytic mechanism [4].
The LMW-PTPs are 18 kDa enzymes, widely expressed in
animal tissues as two isoforms (IF1 and IF2) originating
through alternative splicing, as well as in yeast and in prokar-
yotes [4]. We have previously demonstrated that the LMW-
PTP is involved in mitogenic signal cascades triggered by sev-
eral growth factors, such as insulin and PDGF [5,6]. In par-
ticular, the enzyme interacts with the activated PDGF recep-
tor (PDGF-R) directly through its catalytic site, negatively
a¡ecting both Src and the STAT pathways and leading to
down-regulation of immediately early genes such as c-myc
and c-fos [6]. Recently, we have shown that the LMW-PTP
resides constitutively both in the cytosolic and in the cytoske-
leton-associated fractions; however, it is tyrosine-phospho-
rylated directly by Src only in the cytoskeletal fraction, while
only the enzyme present in the cytosolic fraction is able to
interact with the phosphorylated PDGF-R [7].
Previous results from our and other laboratories demon-
strated that the LMW-PTP is phosphorylated in v-Src trans-
formed NIH-3T3 cells and in resting Jurkatt cells at Tyr131
and, to a lesser extent, at Tyr132, thus becoming activated
[8,9]. However, these data are not conclusive for what the
e¡ective speci¢c activity of the phosphorylated enzyme is con-
cerned. In addition, the possibility of di¡erential e¡ects fol-
lowing the phosphorylation of either tyrosine residue was not
investigated. Therefore, we used Y131A and Y132A LMW-
PTP mutants to study the e¡ects of phosphorylation of each
residue on enzyme behaviour. Furthermore, the ¢nding that
the residues following Tyr132 (Y132-G133-N134-D135) conforms
to the consensus motif recognised by the Grb2 SH2 domain
[10] led us to investigate whether Grb2 was able to bind in
vitro the phosphorylated recombinant LMW-PTP. The re-
ported results are discussed in the light of the LMW-PTP
three-dimensional structure.
2. Materials and methods
Unless otherwise speci¢ed, all reagents were obtained from Sigma;
NIH-3T3 cells were purchased from ATCC; human recombinant
PDGF-BB was from Peprotech; AG1296 was from ICN; Enhanced
Chemi-Luminescence Kit was from Amersham; anti-pp60Src antibod-
ies were from Upstate Biotechnology Inc.; anti-PDGF-R antibodies
and PY20 anti-phosphotyrosine antibodies were from Santa Cruz;
anti-Grb2 monoclonal antibodies (clone 81) were from Transduction
Laboratories. Peptide synthesis reagents were from NovaBiochem
(Switzerland); HATU was from PerSeptive Biosystems.
2.1. Site-directed mutagenesis
The recombinant Y131A, Y132A and Y131A-Y132A LMW-PTP
(isoform 2) mutants were prepared as fusion proteins with GST by
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oligonucleotide-directed mutagenesis using an USE mutagenesis kit
(Pharmacia) based upon the unique site elimination method [11].
Each mutation was con¢rmed by DNA sequencing.
2.2. Expression, puri¢cation and cleavage of GST fusion proteins
The nucleotide sequences of the wild-type and mutant bovine liver
LMW-PTP were cloned in frame with the sequence of the glutathione
S-transferase in the pGEX-2T bacterial expression vector. Enzyme
expression and puri¢cation were achieved in the Escherichia coli
TB1 strain as previously described [12].
2.3. Src and PDGF-R kinase assays
Phosphorylation of wild-type and mutant LMW-PTP was carried
out as previously described [8]. Brie£y, 5 Wg of enzyme was dissolved
in 40 Wl of 25 mM HEPES, pH 7.5, containing 100 mM NaCl, 10 mM
MgCl2, 10 mM MnCl2, 0.1% Nonidet P-40, 10% glycerol, and 50 WM
ATP. The mixture was incubated with 5 units of Src either purchased
from UBI or immunoprecipitated from c-Src overexpressing NIH-3T3
cells stimulated with 30 ng/ml PDGF-BB. Alternatively, the mixture
was incubated with v-Src immunoprecipitated from v-Src overexpress-
ing NIH-3T3 cells (kindly provided by Prof. V. Chiarugi) or in the
presence of the activated PDGF-R immunoprecipitated from PDGF-
stimulated NIH-3T3 cells. [Q-S]ATP was used in the non-radioactive
phosphorylation assays to determine the wild-type or mutant LMW-
PTP activity. The phosphorylation stoichiometry of the wild-type and
mutant LMW-PTPs was calculated by a kinase assay carried out
using [Q-32P]ATP (10 WCi per sample) in the presence of 1 mM vana-
date to prevent enzyme autodephosphorylation. The samples were
incubated for 3 h at 30‡C, resuspended in 4USDS sample bu¡er
and run in SDS-PAGE; ¢nally, the dried gels were autoradiographed.
2.4. PTP assay
LMW-PTP activity was determined as previously reported using
PNPP as a substrate [8]. Kinetic parameters were determined by using
a non-linear ¢tting of the Michaelis equation (Fig. P program, Bio-
soft).
2.5. Immunoprecipitation and Western blot
1U106 cells were seeded in 10 cm plates in DMEM supplemented
with 10% FCS and serum starved for 24 h before receiving 30 ng/ml
PDGF-BB. A freshly made 0.1 mM pervanadate solution (20 Wl of a
solution containing 50 mM sodium vanadate [NaVO4] and 50 mM
H2O2 in 10 ml of medium) was added to the cells 30 min before
stimulation with PDGF. Then, cells were lysed for 20 min in 500 Wl
of ice-cold RIPA lysis bu¡er (50 mM Tris-HCl, pH 7.5, containing
150 mM NaCl, 1% Nonidet P-40, 2 mM EGTA, 1 mM sodium or-
thovanadate, 1 mM PMFS, 10 Wg/ml aprotinin, 10 Wg/ml leupeptin),
centrifuged and immunoprecipitated for 4 h at 4‡C with 1 Wg of the
speci¢c antibodies. Immune complexes were collected on protein
A-Sepharose (Pharmacia), run in SDS-PAGE, and transferred onto
nitrocellulose (Sartorius). Immunoblots were incubated for 1 h at
room temperature in 10 mM Tris-HCl bu¡er, pH 7.5, containing
3.0% bovine serum albumin, 1 mM EDTA and 0.1% Tween-20,
probed with speci¢c antibodies followed by horseradish peroxidase-
conjugated secondary antibodies, washed and developed with the
Enhanced Chemi-Luminescence Kit (Amersham).
2.6. Peptide synthesis and immobilisation
Two 14-mer phosphopeptides (I-I-E-D-P-PY-Y-G-N-D-S-D-F-E
and I-I-E-D-P-Y-PY-G-N-D-S-D-F-E) (PY131 and PY132, respec-
tively) encompassing residues 126^139 in the LMW-PTP sequence
were synthesised in solid phase by the 9-£uorenylmethoxycarbonyl
(Fmoc) chemistry using a MilliGen 9050 PepSynthesizer according
to the manufacturer’s protocol. Phosphotyrosine was incorporated
as Fmoc-Tyr(PO(OBzl)OH)-OH and coupled by HATU coupling re-
agent, all other residues were incorporated as penta£uorophenyl ester
derivatives. Peptide deprotection and cleavage from the resin were
performed by incubating each resin for 2 h at room temperature
with a TFA/TIS/H2O (90:5:5) mixture. The deprotected peptides
were puri¢ed by reverse-phase HPLC on a C18 Vydac (20U250
mm) column and their purity assayed by amino acid analysis and
mass spectrometry. The peptides, dissolved in coupling bu¡er (0.1 M
NaHCO3, pH 8.3, containing 0.5 M NaCl), were covalently coupled
to NHS-activated Sepharose 4 Fast Flow beads (Pharmacia) by over-
night incubation at 4‡C. Then the free groups on the resin were
blocked by 2 h incubation in 1.0 M Tris (pH 8.0). The coupling yield
was monitored by reverse-phase HPLC; typically, 4.0 mg (about
2.3 Wmol) of peptide/ml of beads was coupled.
2.7. Binding assay of Grb2 to the Tyr-phosphorylated peptides and
LMW-PTP
1U106 NIH-3T3 cells were seeded in 10 cm plates in DMEM sup-
plemented with 10% FCS. Whole cells were lysed by incubation for
30 min in 1.0 ml of ice-cold RIPA bu¡er supplemented with protease
and phosphatase inhibitors. The lysates were centrifuged and 0.3 ml
of supernatant was incubated overnight at 4‡C with about 50 Wl of
peptide-bound beads. Then the beads were collected by centrifugation,
washed four times with the lysis bu¡er at room temperature and
eluted with 100 Wl of SDS-PAGE sample bu¡er. The eluted proteins
were analysed by SDS-PAGE and transferred onto nitrocellulose (Sar-
torius). Anti-Grb2 Western blot was performed as described above.
Binding experiments between Grb2 and GST-LMW-PTP, either
wild-type and Y131A or Y132A mutant, were carried out as follows:
equal amounts (50 Wg) of puri¢ed GST-LMW-PTP, either wild-type
and mutant at Y131A or Y132A, were phosphorylated in vitro by Src
(see above). After phosphorylation, complexes were recovered with
glutathione-coupled agarose beads and incubated overnight with an
NIH-3T3 cell lysate (see above) in the presence and in the absence of
PY132 or PY131 (10 WM); each resin was washed with lysis bu¡er and
the proteins, eluted with SDS sample bu¡er, were run in 12% SDS-
PAGE and blotted onto nitrocellulose. Anti-Grb2 Western blot was
performed as described above.
2.8. Computer graphics modeling
A model of the complex of LMW-PTP and GRB2 was constructed
using the program Quanta. The structure of Grb2 was docked on to
the LMW-PTP structure (PDB entry 1PHR) using the peptide bound
to the Grb2 as a guide. The three di¡erent PDB ¢les 1TZE, 1BM2,
1BMB, all containing a Grb2 SH2 domain with bound peptides, were
used for the modeling. All three peptides contain a P-Tyr-X-Asn
sequence. The peptides of the Grb2 structures were positioned so
that phosphotyrosine and Asn side chains were superimposed with
the side chains of Tyr132 and Asn134 of the LMW-PTP.
3. Results
Recent reports from our and other groups showed that Src
is able to phosphorylate in vitro the LMW-PTP, which be-
Table 1
Kinetic parameters and activation upon tyrosine phosphorylation of the wild-type and mutant LMW-PTP
Wild-type Y131A Y132A Y131A-Y132A
kcat (s31) 30.0 þ 0.81 12.6 þ 0.42 20.7 þ 0.53 11.6 þ 0.52
Km (mM) 0.19 þ 0.01 8.45 þ 0.21 0.42 þ 0.01 8.2 þ 0.81
kcat/Km (s31 M31) 103 157.89 1.49 49.32 1.41
Phosphorylation (%) 4.44 1.40 2.96 0
Actual activation upon phosphorylation (fold)a 18.00 (1.78) 1.00 (1.00) 25.00 (1.71) ^
The assays were performed in triplicate and repeated three times using PNPP as a substrate. The amount of tyrosine phosphorylation was eval-
uated using [Q-32P]ATP in the kinase reaction; enzyme activation was assayed after 120 min incubation in the presence of c-Src and [Q-thio]ATP
(see Section 2).
aActual activation is the e¡ective activation of each phosphorylated derivative with respect to the unphosphorylated form. In parentheses are
reported the values of the apparent enzyme activation in the kinase reaction mixture with respect to the unphosphorylated counterpart.
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comes activated about two-fold [8,9]. To further investigate
the molecular features of such phosphorylation, we used the
Y131A, Y132A and Y131A-Y132A enzyme mutants. These
mutants were phosphorylated in vitro by the activated
PDGF receptor immunoprecipitated from stimulated NIH-
3T3 cells, by v-Src or c-Src (see Section 2). The immunopre-
cipitated PDGF-R is able to phosphorylate the LMW-PTP,
and this phosphorylation is strongly reduced in the presence
of AG1296, a speci¢c PDGF-R inhibitor belonging to the
tyrphostin family [13] (not shown). The site(s) of LMW-PTP
phosphorylation by the PDGF-R were investigated by using
either the Y131A, the Y132A or the Y131A-Y132A mutant as
a substrate; we found that the phosphorylation levels of all
mutants were comparable to that of the wild-type enzyme,
indicating that the phosphorylation by PDGF-R can be con-
sidered rather aspeci¢c.
The LMW-PTP tyrosine phosphorylation by the viral and
cellular Src tyrosine kinase was also investigated. We immu-
noprecipitated v-Src from subcon£uent v-Src transformed
NIH-3T3 and c-Src from NIH-3T3 cells serum starved for
24 h and stimulated for 5 min with PDGF-BB. Both v-Src
and c-Src were able to phosphorylate in vitro the enzyme (not
shown). In particular, on the basis of the speci¢c [Q-32P]ATP
radioactivity and of the amount of protein used in the tests,
we calculated a 4% and a 5% extent of tyrosine phosphoryla-
tion in the c-Src and v-Src kinase experiments, respectively;
these values are higher than in the presence of the PDGF-R
kinase. The same in vitro kinase assay was carried out in the
presence of each LMW-PTP mutant (Y131A, Y132A and
Y131A-Y132A). The extent of Y131A and Y132A mutant
phosphorylation by c-Src (very similar results were obtained
in the presence of v-Src) was reduced by 3.2- and 1.5-fold
respectively as compared to the wild-type enzyme, whereas
the Y131A-Y132A mutant phosphorylation was almost unde-
tectable (see Table 1). Therefore, the LMW-PTP phosphoryl-
ation by Src in vitro appears more e¡ective (about 20-fold)
and speci¢c (restricted to only Tyr131 and, to a lesser extent,
Tyr132) with respect to the phosphorylation by the activated
PDGF-R.
To check the e¡ects of phosphorylation on the LMW-PTP
activity, we previously determined the main kinetic parame-
ters of the wild-type and mutant LMW-PTP (Table 1). An
increase (about 45-fold) of the Km values of the Y131A and
Y131A-Y132A mutants and a decrease of the catalytic e⁄-
ciency of Y131A mutant (about 100-fold) can be noted, in-
dicating that Tyr131 is important for the enzyme catalytic ac-
tivity. This ¢nding is not surprising, considering that this
Fig. 1. Phosphorylation at Tyr131 activates the LMW-PTP. In vitro
phosphatase assays of the wild-type and mutant LMW-PTP phos-
phorylated by c-Src. Five Wg of enzyme was incubated at 30‡C with
5 I.U. of c-Src in the presence of [Q-thio]ATP. Four Wl aliquots
were assayed for enzyme activity at the indicated times using PNPP
as a substrate. Percent of activation of the wild-type LMW-PTP
and of the Y131A and Y132A mutants following phosphorylation
by c-Src is reported in panels A, B, and C, respectively. Experi-
ments were carried out in triplicate (S.D.s are indicated).
Fig. 2. Grb2 binds to a Tyr-phosphorylated peptide derived from
the LMW-PTP sequence and to the wild-type and Y131A mutant
enzymes phosphorylated by c-Src. Panel A: 106 NIH-3T3 cells were
lysed and the supernatants were incubated with resin-bound syn-
thetic peptides phosphorylated at Tyr131 (lane 1), Tyr132 (lane 3) or
unphosphorylated (lane 2), as indicated in Section 2. Proteins bound
to each resin peptide were eluted, run in SDS-PAGE and blotted
onto nitrocellulose. The nitrocellulose was incubated with anti-Grb2
monoclonal antibodies (see Section 2). A PC12 cell lysate was used
as a positive control (lane 4). Panel B: Y132A (lane 1), Y131A
(lanes 2, 3 and 4) and wild-type (lanes 5 and 6) LMW-PTP-GST fu-
sion proteins were phosphorylated in vitro by c-Src and recovered
with glutathione-agarose beads (see Section 2). Then each resin pro-
tein was incubated with an NIH-3T3 cell lysate alone (lanes 1, 4 and
6), in the presence of PY132 (lanes 3 and 5) or in the presence of
PY131 (lane 2); each resin was extensively washed and resin-bound
proteins were eluted, run in 12% SDS-PAGE and transferred to a
nitrocellulose sheet. The nitrocellulose was washed, saturated and
incubated with anti-Grb2 antibodies. Immunopositive bands were
revealed by incubation with the horseradish-conjugated secondary
antibody (see Section 2). Lane 7, control of a cell lysate incubated
with GST-agarose; lane 8, positive Grb2 control. Similar results
were obtained in three separate experiments.
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residue is structurally close to the general acid/base catalyst of
the reaction (Asp129). In contrast, the kinetic parameters of
the Y132A mutant are very similar to those shown by the
wild-type enzyme, suggesting a minor role of Tyr132 in the
catalytic machinery. To evaluate the overall speci¢c activity
of the enzyme phosphorylated at either Tyr131 or Tyr132, a
kinase assay in the presence of [Q-S]ATP was performed.
Fig. 1A shows that, after 120 min incubation, the apparent
activity of the wild-type enzyme rises to about 200%. Enzyme
labelling with [Q-32P]ATP allowed to estimate the amount of
LMW-PTP that is phosphorylated within the same time inter-
val (about 4%). On the basis of these data, we calculated an
average 18-fold activation of the mixture of the wild-type
LMW-PTP molecules phosphorylated at either Tyr131 or
Tyr132 or unphosphorylated with respect to the unmodi¢ed
enzyme (Table 1, left column). To analyse the relative contri-
bution of both Tyr131 and Tyr132 to enzyme activation, the
same phosphorylation experiments were performed using the
Y131A and Y132A mutants. Tyr132 phosphorylation has no
e¡ect on the enzyme activity (Fig. 1B), whereas only Tyr131
phosphorylation is followed by enzyme activation (Fig. 1C).
The phosphorylation stoichiometry and the extent of the mu-
tant LMW-PTP activation upon phosphorylation are depicted
in Table 1. While the Y131A mutant does not show any
detectable activation, a sharp increase in enzymatic activity
of the Y132A mutant (about 25-fold) can be noted. The high-
er activation of the Y132A mutant with respect to that calcu-
lated for the wild-type enzyme (about 18-fold) can be ex-
plained considering that the latter is phosphorylated also at
Tyr132, that does not contribute to enzyme activation.
Since the sequence C-terminal to Tyr132 conforms to the
motif speci¢cally recognised by the Grb2 SH2 domain (Y-
X-N) [10], the possibility that PTyr132 could be a recruitment
site for such a docking protein was investigated by performing
two binding experiments in vitro. The ¢rst experiment was
carried out using three synthetic peptides encompassing the
sequence around Tyr131-Tyr132 di¡ering from each other in
the phosphate group position. The control peptide was not
phosphorylated, whereas peptides PY131 and PY132 contained
a phosphotyrosine residue corresponding, in the LMW-PTP
sequence, to Tyr131 or Tyr132, respectively. The peptides were
bound to NHS-activated Sepharose 4 Fast Flow beads (see
Section 2). The resins containing the control PY131 and PY132
peptides were separately incubated with an NIH-3T3 cell ly-
sate, washed and eluted; the eluted proteins were run in SDS-
PAGE in duplicate. One slab was silver stained and the other
slab was blotted onto nitrocellulose. The stained slab (not
reported) showed a sharp 25 kDa band that was absent
when the NIH-3T3 cell lysate was run through the resins
containing the control peptide or the PY131 peptide. The
Western blot analysis of the second slab showed that the 25
kDa protein was immunoreactive with anti-Grb2 antibodies
(Fig. 2A), thus indicating the possibility of a speci¢c interac-
tion of this docking protein with the LMW-PTP phosphoryl-
ated at Tyr132.
To assess this possibility, we performed a second binding
experiment using GST-LMW-PTP, either wild-type and mu-
tant at Tyr131 or Tyr132, phosphorylated by c-Src. The phos-
phorylated enzymes were captured with glutathione beads and
incubated with NIH-3T3 lysates in the presence and in the
absence of the PY132 or PY131 (see Section 2). Fig. 2B shows
the results of the Western blot with anti-Grb2 antibodies. A
25 kDa protein immunoreactive with anti-Grb2 antibodies
associated with the phosphorylated GST-LMW-PTP, either
wild-type and mutant at Tyr131 (lanes 6 and 4, respectively) ;
the addition of PY132 strongly inhibited such a binding (lanes
5 and 3, respectively), whereas the Grb2/Y131A complex was
not a¡ected by the presence of PY131 (lane 2). Both the
Fig. 3. Outline of the LMW-PTP IF2 structure. A: The positions
and the relative orientations of the Tyr131 and Tyr132 and N134 side
chains (ball and stick) are depicted (drawn by WebLab Wiever pro-
gram). B: Molecular model of the complex between LMW-PTP and
the Grb2 SH2 domain. The LMW-PTP (PDB entry 1PHR) (bot-
tom) and Grb2 SH2 domain (PDB entry 1BM2) (top) are depicted
together with the Grb2 binding peptide (in dark lines) (drawn by
Molscript, Kraulis). The LMW-PTP orientation is the same in A
and B.
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Y132A mutant and the GST alone were not able to associate
to Grb2 (lanes 5 and 7, respectively) ; the unphosphorylated
enzyme did not bind Grb2 (data not shown). These results
indicate that the LMW-PTP/Grb2 interaction is speci¢cally
relieved only by PY132, thus con¢rming the data about the
interaction between Grb2 and the phosphorylated peptides.
They also demonstrate that the Grb2/phosphorylated LMW-
PTP interaction is speci¢c, depending on the presence, in the
enzyme, of the typical Grb2 binding sequence (PY-G-N-D)
including PTyr132.
The molecular features of the interaction between Grb2 and
the Tyr132-phosphorylated LMW-PTP were further assessed
by molecular modeling (see Section 2). Computer graphic
models of possible complexes between LMW-PTP and Grb2
could be assembled in slightly di¡erent ways depending on
which of the two available Grb2 peptide complexes was
used (PDB ¢le 1TZE and 1BM2, 1BMB). However, none of
the models led to steric clashes between Grb2 and LMW-PTP,
which supports the feasibility of an interaction of the Grb2
SH2 domain with the Tyr132-phosphorylated enzyme (Fig.
3B).
4. Discussion
The aim of the present paper was to address the e¡ects of
phosphorylation at either Tyr131 or Tyr132 on the LMW-PTP
behaviour by using mutants at these residues. All mutants,
particularly the Y131A mutant, displayed signi¢cant di¡eren-
ces in the main kinetic parameters with respect to the wild-
type enzyme. Previously reported data [8,9,14] showed a phos-
phorylation of the enzyme by Src kinases and by the Eph
receptor kinase and that the former is speci¢cally targeted
to Tyr131 and Tyr132 and is followed by enzyme activation.
However, the possibility of a di¡erential contribution of
Tyr131 and Tyr132 phosphorylation in enzyme activation was
not investigated, nor the e¡ective activation of the phospho-
rylated enzyme. By using Y131A and Y132A mutants, we
have shown that the speci¢c activity of the LMW-PTP phos-
phorylated at Tyr131 increases by roughly 25-fold, whereas
phosphorylation at Tyr132 leaves enzyme activity unchanged.
These results strengthen the previously reported ¢ndings on
the LMW-PTP phosphorylation in vivo by Src kinases [9],
further indicating that such a modi¢cation does have some
biological and functional signi¢cance.
In the mammalian LMW-PTPs (but not in the correspond-
ing enzymes from yeasts and prokaryotes), Tyr132 is followed
by the conserved sequence G-N-D, which conforms to the
consensus motif for phosphotyrosine recognition by the
Grb2 SH2 domain (PY-X-N-X) [10]. We have shown that
Grb2 binds in vitro synthetic phosphopeptides derived from
the LMW-PTP sequence around Tyr131-Tyr132 and to the en-
zyme phosphorylated in vitro by Src at Tyr132, indicating that
this enzyme derivative is speci¢cally recognised by Grb2 (most
likely at the level of the SH2 domain). The physiological sig-
ni¢cance of the LMW-PTP/Grb2 interaction needs to be fur-
ther addressed. For example, it could target the Tyr132-phos-
phorylated enzyme to speci¢c locations into the cell ; in fact,
the LMW-PTP phosphorylated by c-Src has recently been
found in the cytoskeletal fraction whereas only the cytosolic
fraction of the enzyme is able to interact with the activated
PDGF-R [7].
The di¡ering e¡ects following LMW-PTP phosphorylation
can tentatively be explained on the basis of the X-ray struc-
tural data of the LMW-PTP isoforms 1 and 2 [15,16], showing
that both isoforms display very similar structures, particularly
with regard to the position of the Tyr131-Tyr132 cluster. How-
ever, it is worth noting that these structures refer to enzymes
complexed with substrate analogs and hence could di¡er in
some features with respect to that of the substrate-free enzyme
(the Src kinase substrate in our experiments), by analogy with
previously reported structural data on PTP1B and Yersinia
PTPase. In fact, upon substrate binding, these enzymes under-
go a conformational reorganisation involving the WpD loop
containing the catalytic aspartic acid, which moves to its cat-
alytically competent position into the active site [17^19]. Fig.
3A shows that the Tyr131 side chain lies on the border of the
crevice harbouring the catalytic site, while the Tyr132 side
chain stretches out from protein surface. It can also be seen
that the Tyr132-Asn134 sequence in the 114^136 loop is fully
accessible. Therefore, it is conceivable that Tyr132 has a minor
role in the enzyme kinetic behaviour, whereas its phosphoryl-
ation can generate a solvent exposed, fully accessible docking
site suitable to speci¢cally recruit SH2 containing proteins.
Instead, phosphorylation at Tyr131 might a¡ect the P-loop
conformation leading to enzyme activation possibly by in-
creasing the kcat value for phosphoenzyme hydrolysis (the
rate-limiting step of the catalytic mechanism) by analogy
with the previously reported activation mechanism by
cGMP [20]. It appears intriguing that the alternative phos-
phorylation of adjacent residues by the same kinase sharply
modulates di¡ering LMW-PTP functions such as enzyme ac-
tivity and recruitment of SH2 proteins. Overall, from these
and other previously reported data on the e¡ect of cGMP,
NO, and H2O2 on the LMW-PTP activity [20^22], a picture
does emerge indicating the existence of a complex pattern of
regulation of this enzyme.
Considering the close proximity of Tyr132 to the active site
crevice, we can expect that the interaction of Grb2 with the
phosphorylated LMW-PTP a¡ects the access of the ligand
binding surface and active site entrance which could lead to
enzyme inactivation. In the model of the LMW-PTP/Grb2
complex (Fig. 3B), the enzyme active site appears not com-
pletely blocked and is still accessible for low molecular weight
substrates such as phosphopeptides. However, it is clear that
complex formation would block the access to the active site of
high molecular weight substrates, such as phosphorylated pro-
teins. These considerations lead to hypothesise that the phos-
phorylation state of either tyrosine residue can be considered
as a molecular switch controlling the level of enzyme activity
and/or the substrate speci¢city of the enzyme. It is known that
SH2 domain PTPs such as SHP2 and PTPK are inhibited
intramolecularly through a steric block of the catalytic cleft
by the SH2 domain from the protein itself and that such a
steric hindrance is relieved by the interaction with a peptide
substrate [23]. A similar mechanism of intramolecular inhib-
ition is shown by SH2 kinases such as the Src family enzymes.
Therefore, when demonstrated, the modulation of the Tyr132-
phosphorylated enzyme bound to Grb2 could be considered
as a variation of a most general strategy, leading to control
the catalytic activity of such a single-domain PTP by an in-
termolecular (rather than intramolecular) SH2 domain inter-
action.
Recently, an accurate study on the phosphorylation of
PTP1B on tyrosine has been reported [24]. PTP1B becomes
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phosphorylated at Tyr66 upon binding to the EGF receptor,
and the speci¢c activity of the enzyme mixture containing the
phosphorylated derivative rises to about 300%. A 12% phos-
phorylation stoichiometry was found, leading to roughly cal-
culate a 20-fold increase of the speci¢c activity of the Tyr66-
phosphorylated PTP1B, a value very similar to that calculated
for the Tyr131-phosphorylated LMW-PTP (about 25-fold); in
addition, the phosphorylated PTP1B recruits Grb2. However,
in this case, catalytic activity enhancement and Grb2 binding
are triggered by the phosphorylation of the same Tyr residue.
Other PTPs, such as PTP1C and SHP-2 [25,26] are activated
upon phosphorylation at speci¢c tyrosine residues; in addi-
tion, a number of PTPs have been shown to interact with SH2
containing targets following tyrosine phosphorylation. Phos-
phorylation at Tyr542 or Tyr584 by the PDGF-R makes SHP-2
able to recruit the adapter protein Grb2 thus modulating
downstream events such as the Ras pathway [27,28] ; RPTPK
phosphorylated at Tyr789 recruits Grb2 [29]. Therefore, our
data add to a number of previously reported ¢ndings, sup-
porting the conclusion that phosphorylation at speci¢c tyro-
sine residues is one of the main mechanisms by which many
PTPs ¢nely tune their catalytic activity as well as their ability
to interact with other proteins.
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